摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-oxo-1,2,5,6-tetrahydro-[1,1′-biphenyl]-3-yl propionate | 1609374-79-9

中文名称
——
中文别名
——
英文名称
5-oxo-1,2,5,6-tetrahydro-[1,1′-biphenyl]-3-yl propionate
英文别名
——
5-oxo-1,2,5,6-tetrahydro-[1,1′-biphenyl]-3-yl propionate化学式
CAS
1609374-79-9
化学式
C15H16O3
mdl
——
分子量
244.29
InChiKey
SCAMIVORZKCOGX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.97
  • 重原子数:
    18.0
  • 可旋转键数:
    3.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    43.37
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

反应信息

  • 作为产物:
    描述:
    5-phenyl-cyclohexane-1,3-dione丙酰氯4-二甲氨基吡啶N,N-二异丙基乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 2.0h, 以64%的产率得到5-oxo-1,2,5,6-tetrahydro-[1,1′-biphenyl]-3-yl propionate
    参考文献:
    名称:
    Novel Colchicine-Site Binders with a Cyclohexanedione Scaffold Identified through a Ligand-Based Virtual Screening Approach
    摘要:
    Vascular disrupting agents (VDAs) constitute an innovative anticancer therapy that targets the tumor endothelium, leading to tumor necrosis. Our approach for the identification of new VDAs has relied on a ligand 3-D shape similarity virtual screening (VS) approach using the ROCS program as the VS tool and as query colchicine and TN-16, which both bind the alpha,beta-tubulin dimer. One of the hits identified, using TN-16 as query, has been explored by the synthesis of its structural analogues, leading to 2-(1-((2-methoxyphenyl)amino)ethylidene)-5-phenylcyclohexane-1,3-dione (compound 16c) with an IC50 = 0.09 +/- 0.01 mu M in HMEC-1 and BAEC, being 100-fold more potent than the initial hit. Compound 16c caused cell cycle arrest in the G2/M phase and interacted with the colchicine-binding site in tubulin, as confirmed by a competition assay with N,N'-ethylenebis(iodoacetamide) and by fluorescence spectroscopy. Moreover, 16c destroyed an established endothelial tubular network at 1 mu M and inhibited the migration and invasion of human breast carcinoma cells at 0.4 mu M. In conclusion, our approach has led to a new chemotype of promising antiproliferative compounds with antimitotic and potential VDA properties.
    DOI:
    10.1021/jm401939g
点击查看最新优质反应信息